Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
This paper addresses pharmacoeconomics in prescribing research and reflects the increasing use of techniques of economic evaluation to aid drug purchasing decisions in a variety of settings -- for national drug subsidization programmes, provincial purchasing plans, insurance programmes, and for hospital and area health authority formulary decisions. First, we focus on the cost component of an economic evaluation and discuss methodological issues that are relevant to all pharmacoeconomic analyses.
Robertson
J
J
Clinical Pharmacology, School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, NSW Australia. jroberts@mail.newcastle.edu.au
Lang
D
D
Hill
S
S
D003363:Cost Control; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D011307:Drug Prescriptions; D017723:Drug Utilization Review / Q000379:methods*; D017850:Economics, Pharmaceutical; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D012107:Research Design
D004364:Pharmaceutical Preparations